Dr Michael J. Burt, Our people, University of Otago, Christchurch

BMedSc MB ChB(Otago) PhD(Q'ld) FRACP

Email michael.burt@cdhb.govt.nz

Department of Gastroenterology
Christchurch Hospital
Private Bag 4710
Christchurch
New Zealand

Current Roles

Senior Lecturer in Medicine
Consultant Gastroenterologist, Christchurch Hospital

Research Interests

Liver disease
Inflammatory bowel disease

Top 10 Publications

Burt MJ, Smit DJ, Pyper WR, Powell LW, Jazwinska EC. A 4.5 megabase YAC contig and physical map over the hemochromatosis gene region. Genomics 1996; 33: 153-8.
Burt MJ, George PM, Upton JD, Collett JA, Frampton CMA, Chapman TM, Walmsley TA, Chapman BA. The significance of haemochromatosis gene mutations in the general population: implications for screening. Gut 1998; 43: 830-6.
Chapman BA, Burt MJ, Chisholm RJ, Allan RB, Yeo KHJ, Ross AG. Dissolution of gallstones with simvastatin, an HMG CoA reductase inhibitor. Dig Dis Sci 1998; 43: 349-53.
Thomas PD, Turner JG, Dobbs BR, Burt MJ, Chapman BA. Use of 99mTc-DISIDA biliary scanning with morphine provocation for the detection of elevated sphincter of Oddi basal pressure. Gut 2000; 46: 838-41
Cook HB, Burt MJ, Collett JA, Whitehead MR, Frampton CMA, Chapman BA. Adult coeliac disease: Prevalence and significance. J Gastroenterol Hepatol 2000; 15: 1032-1036.
Chapman BA, Burt MJ, Frampton CMA, Chapman TM, Whitehead MR, Upton JD, George PM. Influence of haemochromatosis gene mutations on treatment outcomes in patients with hepatitis C. Int Med J 2001; 31:254-5
Burt MJ, Frizelle FA, Barbezat GO. Pregnancy and Exposure to Infliximab (anti-tumor necrosis factor-alpha monoclonal antibody). J Gastroenterol Hepatol 2003; 18: 465-6.
Thiopurine S-methyltransferase (TPMT) genotype does not predict adverse drug reactions to thiopurine drugs in patients with inflammatory bowel disease. Gearry RB, Barclay ML, Burt MJ, Collett JA, Chapman BA, Roberts RL, Kennedy MA Aliment Pharmacol Ther 2003; 18: 395-400.
A thirty-year (1970-1999) study of coeliac disease in the Canterbury region of New Zealand. Cook HB, Oxner RB, Chapman BA, Frampton CMA, Burt MJ. NZ Med J 2004; www.nzma.org.nz/journal/117-1189/772
Surveillance for dysplasia in patients with inflammatory bowel disease: A national survey of colonoscopic practice in New Zealand. Gearry RB, Wakeman CJ, Barclay ML, Chapman BA, Collett JA, Burt MJ, Frizelle FA. Dis Colon Rectum 2004; 47: 314-22

Publications

Mules, T., Stedman, C. A., Ding, S., Burt, M., Gearry, R., Chalmers-Watson, T., Falvey, J., Chapman, B., Barclay, M. L., Lim, G., … Ngu, J. H. (2020). The ABC score accurately predicts mortality in hospitalized patients that develop upper gastrointestinal bleeding. Gastrointestinal Endoscopy, 91(6, Suppl.), (pp. AB590-AB591). doi: 10.1016/j.gie.2020.03.3668 Conference Contribution - Published proceedings: Abstract

Lamba, M., Daker, C., Metcalf, S., Burt, M., Stedman, C., Chapman, B., & Ngu, J. (2018). Are patients with chronic hepatitis B receiving recommended HCC surveillance? Proceedings of the New Zealand Society of Gastroenterology and the NZNO Gastroenterology Nurses' College Annual Scientific Meeting. Retrieved from http://gastro2018.co.nz Conference Contribution - Published proceedings: Abstract

Lamba, M., Burt, M., Alamri, Y., Falvey, J., & Gearry, R. (2017). Predictors of non-attendance at outpatient endoscopy appointments: Five year Canterbury study. Proceedings of the New Zealand Society of Gastroenterology and the NZNO Gastroenterology Nurses' College Annual Scientific Meeting. 37. Retrieved from http://gastro2017.co.nz Conference Contribution - Published proceedings: Abstract

Sanders, A. D., Stevenson, C., Pearson, J., Burt, M., McGeoch, G., Hudson, B., & Eglinton, T. W. (2013). A novel pathway for investigation of colorectal symptoms with colonoscopy or computed tomography colonography. New Zealand Medical Journal, 126(1382). Retrieved from http://www.nzma.org.nz/journal Journal - Research Article

Gardiner, S. J., Gearry, R. B., Burt, M. J., Chalmers-Watson, T., Chapman, B. A., Ross, A. G., Stedman, C. A. M., … Barclay, M. L. (2011). Allopurinol might improve response to azathioprine and 6-mercaptopurine by correcting an unfavorable metabolite ratio. Journal of Gastroenterology & Hepatology, 26(1), 49-54. doi: 10.1111/j.1440-1746.2010.06489.x Journal - Research Article

2020

Conference Contribution - Published proceedings: Abstract

2018

Conference Contribution - Published proceedings: Abstract

2017

Conference Contribution - Published proceedings: Abstract

2013

Journal - Research Article

2011

Journal - Research Article

2010

Journal - Research Article

Ngu, J. H., Bechly, K., Chapman, B. A., Burt, M. J., Barclay, M. L., Gearry, R. B., & Stedman, C. A. M. (2010). Population-based epidemiology study of autoimmune hepatitis: A disease of older women? Journal of Gastroenterology & Hepatology, 25(10), 1681-1686. doi: 10.1111/j.1440-1746.2010.06384.x

Conference Contribution - Published proceedings: Abstract

Ngu, J. H., Wright, A., Gearry, R. B., Chapman, B. A., Burt, M. J., Barclay, M. L., & Stedman, C. A. M. (2010). Primary biliary cirrhosis in Canterbury, New Zealand: A population-based study. Journal of Gastroenterology and Hepatology. 25(Suppl. 2), (pp. A11). doi: 10.1111/j.1440-1746.2009.06462.x

Ngu, J. H., Wright, A., Gearry, R. B., Chapman, B. A., Burt, M. J., Barclay, M. L., & Stedman, C. A. M. (2010). Population-based epidemiology of primary sclerosing cholangitis in Canterbury, New Zealand. Journal of Gastroenterology and Hepatology. 25(Suppl. 2), (pp. A11). doi: 10.1111/j.1440-1746.2009.06462.x

2009

Conference Contribution - Poster Presentation (not in published proceedings)

Ngu, J. J. H., Wright, A., Gearry, R. B., Chapman, B. A., Burt, M. J., Barclay, M. L., & Stedman, C. A. M. (2009, November). Primary sclerosing cholangitis in Canterbury: High incidence and prevalence with reduced life expectancy. Poster session presented at the New Zealand Society of Gastroenterology & NZNO Gastroenterology Nurses Section Annual Scientific Meeting, Wellington, New Zealand.

Conference Contribution - Verbal presentation and other Conference outputs

Ngu, J. J. H., Wright, A., Gearry, R. B., Chapman, B. A., Burt, M. J., Barclay, M. L., & Stedman, C. A. M. (2009, November). Population-based epidemiology of primary biliary cirrhosis in Canterbury, New Zealand. Verbal presentation at the New Zealand Society of Gastroenterology & NZNO Gastroenterology Nurses Section Annual Scientific Meeting, Wellington, New Zealand.

Ngu, J. J. H., Bechly, K., Gearry, R. B., Chapman, B. A., Burt, M. J., Barclay, M. L., & Stedman, C. A. M. (2009, November). Population-based epidemiology study of autoimmune hepatitis: A disease of older women? Verbal presentation at the New Zealand Society of Gastroenterology & NZNO Gastroenterology Nurses Section Annual Scientific Meeting, Wellington, New Zealand.

2008

Journal - Research Article

Roberts, R. L., Gearry, R. B., Bland, M. V., Sies, C. W., George, P. M., Burt, M., … Barclay, M. L., & Kennedy, M. A. (2008). Trinucleotide repeat variants in the promoter of the thiopurine S-methyltransferase gene of patients exhibiting ultra-high enzyme activity. Pharmacogenetics & Genomics, 18(5), 434-438.

Gardiner, S. J., Gearry, R. B., Burt, M. J., Ding, S. L., & Barclay, M. L. (2008). Severe hepatotoxicity with high 6-methylmercaptopurine nucleotide concentrations after thiopurine dose escalation due to low 6-thioguanine nucleotides. European Journal of Gastroenterology & Hepatology, 20(12), 1238-1242. doi: 10.1097/MEG.0b013e3282ffda37

Journal - Research Other

Ganly, P., Saleem, M., Marr, H., Burt, M., Florkowski, C., & Williamson, A. (2008). Not walking or communicating: Is all well? [Case report]. Lancet, 372(9655), 2086. doi: 10.1016/S0140-6736(08)61870-X

Conference Contribution - Published proceedings: Abstract

Barclay, M. L., Gardiner, S. J., Gearry, R. B., Burt, M. J., Chalmers-Watson, T., Chapman, B. A., … Stedman, C. A. M. (2008). Allopurinol may improve response to azathioprine and 6-mercaptopurine by correcting an unfavorable metabolite ratio. Journal of Gastroenterology and Hepatology. 23(Suppl. 4), (pp. A194). [Abstract]

Barclay, M. L., Gardiner, S. J., Gearry, R. B., Burt, M. J., Chalmers-Watson, T., Chapman, B. A., … Stedman, C. A. M. (2008). Allopurinol may improve response to azathioprine and 6-mercaptopurine by correcting an unfavourable metabolite ratio. Proceedings of the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists New Zealand Annual Scientific Meeting. ASCEPT. Retrieved from http://phal.otago.ac.nz/ascept_docos/programme%202008.pdf

2007

Journal - Research Article

Gearry, R. B., Roberts, R. L., Burt, M. J., Frampton, C. M. A., Chapman, B. A., Collett, J. A., Shirley, P., Allington, M. D. E., Kennedy, M. A., & Barclay, M. L. (2007). Effect of inflammatory bowel disease classification changes on NOD2 genotype-phenotype associations in a population-based cohort. Inflammatory Bowel Diseases, 13(10), 1220-1227.

Conference Contribution - Published proceedings: Abstract

Roberts, R. L., Gearry, R. B., Bland, M. V., Sies, C., George, P. M., Burt, M., Kennedy, M. A., & Barclay, M. L. (2007). Trinucleotide repeat variants in inflammatory bowel disease patients exhibiting ultra-high thiopurine S-methyltransferase activity. Proceedings of the 3rd Annual Carney Pharmacogenomics Symposium. Retrieved from http://www.chmeds.ac.nz/research/carneycentre/symposium.htm

Ngu, J. H., Bechly, K., Gearry, R. B., Chapman, B. A., Burt, M. J., Barclay, M. L., & Stedman, C. A. M. (2007). Prevalence of autoimmune hepatitis in Canterbury, New Zealand: A retrospective population based survey. New Zealand Medical Journal, 120(1266). Retrieved from http://journal.nzma.org.nz/journal/120-1266/2848/content.pdf

Gearry, R. B., Frampton, C. M., Collett, J. A., Chapman, B. A., Burt, M. J., Shirley, P. M., & Barclay, M. L. (2007). Inflammatory bowel disease (IBD) related morbidity in a population-based cohort. Gut. 56(Suppl. III), (pp. A127). [Abstract]

Conference Contribution - Verbal presentation and other Conference outputs

Roberts, R. L., Gearry, R. B., Bland, M. V., Sies, C. W., George, P. M., Burt, M., Kennedy, M. A., & Barclay, M. L. (2007, October). Promoter insertion in an inflammatory bowel disease patient exhibiting ultra-high thiopurine S-methyltransferase activity. Verbal presentation at the Joint Cold Spring Harbor Laboratory/Wellcome Trust Conference, Cold Spring Harbor, New York.

Roberts, R. L., Gearry, R. B., Bland, M. V., Sies, C. W., George, P. M., Burt, M., Kennedy, M. A., & Barclay, M. L. (2007, September). Trinucleotide repeat variants in inflammatory bowel disease patients exhibiting ultra-high thiopurine S-methyltransferase activity. Verbal presentation at the 3rd Annual Carney Pharmacogenomics Symposium, Christchurch, New Zealand.

Ngu, J. H., Bechly, K., Gearry, R. B., Chapman, B. A., Burt, M. J., Barclay, M. L., & Stedman, C. A. M. (2007, November). Prevalence of autoimmune hepatitis in Canterbury, New Zealand: A retrospective population based survey. Verbal presentation at the New Zealand Society of Gastroenterology & NZNO Gastroenterology Nurses Section Annual Scientific Meeting combined with the RACP and IMSANZ, Christchurch, New Zealand.

2006

Journal - Research Article

Gearry, R. B., Richardson, A., Frampton, C. M., Collett, J. A., Burt, M. J., Chapman, B. A., & Barclay, M. L. (2006). High incidence of Crohn's disease in Canterbury, New Zealand: Results of an epidemiologic study. Inflammatory Bowel Diseases, 12(10), 936-943.

Conference Contribution - Published proceedings: Abstract

Gearry, R. B., Richardson, A., Frampton, C. M., Chapman, B. A., Burt, M. J., Collett, J. A., & Barclay, M. L. (2006). High rate of Crohn's disease in Canterbury, New Zealand: Results of a population-based study. Gastroenterology. 130(4, Suppl. 2), (pp. A-622). [Abstract]

Gearry, R. B., Frampton, C. M., Collett, J. A., Chapman, B. A., Burt, M. J., Shirley, P., & Barclay, M. L. (2006). Inflammatory bowel disease (IBD) related morbidity in a population-based cohort. Journal of Gastroenterology & Hepatology, 21(Suppl. 4), (pp. A274). doi: 10.1111/j.1440-1746.2006.04687.x

Gearry, R. B., Roberts, R. L., Frampton, C. M., Burt, M. J., Collett, J. A., Chapman, B. A., Allington, M. D., Kennedy, M. A., & Barclay, M. L. (2006). From Vienna to Montreal: The impact of changes in IBD classification on CARD15 genotype-phenotype relationships in a population-based cohort. Journal of Gastroenterology & Hepatology, 21(Suppl. 4), (pp. A271). doi: 10.1111/j.1440-1746.2006.04687.x

Gearry, R. B., Richardson, A., Frampton, C. M., Collett, J. A., Dodgshun, A., Chapman, B. A., Burt, M. J., & Barclay, M. L. (2006). Environmental factors associated with ulcerative colitis: A population-based case-control study. Journal of Gastroenterology & Hepatology, 21(Suppl. 4), (pp. A271). doi: 10.1111/j.1440-1746.2006.04687.x

Gearry, R. B., Richardson, A., Frampton, C. M., Collett, J. A., Dodgshun, A., Chapman, B. A., Burt, M. J., & Barclay, M. L. (2006). Environmental factors associated with Crohn's disease: A population-based case-control study. Journal of Gastroenterology & Hepatology, 21(Suppl. 4), (pp. A270). doi: 10.1111/j.1440-1746.2006.04687.x

Gearry, R. B., Richardson, A., Frampton, C. M., Collett, J. A., Dodgshun, A., Chapman, B. A., Burt, M. J., & Barclay, M. L. (2006). Environmental factors associated with Crohn's disease: A population-based case-control study. Gastroenterology. 130(4, Suppl. 2), (pp. A-621). [Abstract]

Gearry, R. B., Roberts, R. L., Frampton, C. M., Burt, M. J., Collett, J. A., Chapman, B. A., Allington, M. D., Kennedy, M. A., & Barclay, M. L. (2006). From Vienna to Montreal: The impact of changes in IBD classification on CARD15 genotype-phenotype relationships in a population-based cohort. Gastroenterology. 130(4, Suppl. 2), (pp. A-586). [Abstract]

Gearry, R. B., Richardson, A., Frampton, C. M., Collett, J. A., Dodgshun, A., Chapman, B. A., Burt, M. J., & Barclay, M. L. (2006). Environmental factors associated with ulcerative colitis: A large population-based case-control study. Gastroenterology. 130(4, Suppl. 2), (pp. A-137). [Abstract]

Conference Contribution - Verbal presentation and other Conference outputs

Gearry, R., Frampton, C., Collett, J., Chapman, B., Burt, M., Shirley, P., & Barclay, M. (2006, November). Inflammatory bowel disease (IBD) related morbidity in a population-based cohort. Verbal presentation at the New Zealand Society of Gastroenterology NZNO Gastroenterology Nurses Section Annual Scientific Meeting, Blenheim, New Zealand.

2004

Journal - Research Article

Gearry, R. B., Barclay, M. L., Burt, M. J., Collett, J. A., & Chapman, B. A. (2004). Thiopurine drug adverse effects in a population of New Zealand patients with inflammatory bowel disease. Pharmacoepidemiology & Drug Safety, 13(8), 563-567.

Cook, B., Oxner, R., Chapman, B., Whitehead, M., & Burt, M. (2004). A thirty-year (1970-1999) study of coeliac disease in the Canterbury region of New Zealand. New Zealand Medical Journal, 117(1189). Retrieved from http://journal.nzma.org.nz/journal/117-1189/772/content.pdf

Gearry, R. B., Wakeman, C. J., Barclay, M. L., Chapman, B. A., Collett, J. A., Burt, M. J., & Frizelle, F. A. (2004). Surveillance for dysplasia in patients with inflammatory bowel disease: A national survey of colonoscopic practice in New Zealand. Diseases of the Colon & Rectum, 47(3), 314-322.

Conference Contribution - Published proceedings: Abstract

Gearry, R., Barclay, M., Burt, M., Chapman, B., Collett, J., & George, P. (2004). Comparison of faecal calprotectin and clinical disease indices for assessing inflammation in Crohn's disease. New Zealand Medical Journal, 117(1195). Retrieved from http://journal.nzma.org.nz/journal/117-1195/916/content.pdf

2003

Journal - Research Article

Gearry, R. B., Barclay, M. L., Burt, M. J., Collett, J. A., Chapman, B. A., Roberts, R., & Kennedy, M. A. (2003). Thiopurine S-methyltransferase (TPMT) genotype does not predict adverse drug reactions to thiopurine drugs in patients with inflammatory bowel disease. Alimentary Pharmacology & Therapeutics, 18, 395-400.

Journal - Research Other

Burt, M. J., Frizelle, F. A., & Barbezat, G. O. (2003). Pregnancy and exposure to infliximab (anti-tumor necrosis factor-alpha monoclonal antibody) [Letter to the Editor]. Journal of Gastroenterology & Hepatology, 18, 465-466.

Journal - Professional & Other Non-Research Articles

Gearry, R. B., Bramwell Cook, H., & Burt, M. J. (2003). Time for gastroscopy [Medical image]. New Zealand Medical Journal, 116(1168). Retrieved from http://journal.nzma.org.nz/journal/116-1168/309/content.pdf

Conference Contribution - Published proceedings: Abstract

Wakeman, C. J., Gearry, R. B., Frizelle, F. A., Barclay, M. L., Chapman, B. A., Burt, M. J., & Collett, J. (2003). A survey of colonoscopic surveilance for dysplasia in patients with ulcerative colitis. ANZ Journal of Surgery, 73(Suppl.), (pp. A13-A14). doi: 10.1046/j.1445-2197.73.s.3.x

2002

Conference Contribution - Published proceedings: Abstract

Barclay, M. L., Gearry, R. B., Burt, M. J., & Collett, J. A. (2002). Azathioprine and 6-mercaptopurine adverse effects and TPMT genotype in patients with inflammatory bowel disease. Proceedings of the Australian Health and Medical Research Congress 2002. (pp. 1345). Australia: National Health & Medical Research Council. [Abstract]

Conference Contribution - Verbal presentation and other Conference outputs

Barclay, M. L., Gearry, R. B., Burt, M. J., Collett, J. A., Roberts, R. L., & Kennedy, M. A. (2002, August). Azathioprine and 6-mercaptopurine adverse effects and TPMT genotype in patients with inflammatory bowel disease. Verbal presentation at the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT) Meeting, Christchurch, New Zealand.

Barclay, M. L., Gearry, R. B., Burt, M. J., Collett, J. A., Roberts, R. L., & Kennedy, M. A. (2002, November). Azathioprine and 6-mercaptopurine adverse effects and TPMT genotype in patients with inflammatory bowel disease. Verbal presentation at the Annual Meeting of the New Zealand Society of Gastroenterology, Auckland, New Zealand.

2001

Journal - Research Article

Chapman, B. A., Burt, M. J., Frampton, C. M., Chapman, T. M., Whitehead, M. R., Upton, J. D., & George, P. M. (2001). The influence of haemochromatosis gene mutations on treatment outcome in patients with hepatitis C. Internal Medicine Journal, 31, 254-255.

2000

Journal - Research Article

Chapman, B. A., Burt, M. J., Frampton, C. M., Collett, J., Yeo, K. H. J., Wilkinson, I. D., … Barclay, M. L., … George, P. M. (2000). The prevalence of viral hepatitis (HAV, HBV & HCV) in the Christchurch community. New Zealand Medical Journal, 113(1118), 394-396.

Bramwell Cook, H., Burt, M. J., Collett, J. A., Whitehead, M. R., Frampton, C. M., & Chapman, B. A. (2000). Adult coeliac disease: Prevalence and clinical significance. Journal of Gastroenterology & Hepatology, 15(9), 1032-1036.

Chapman, B. A., Burt, M. J., Frampton, C. M., Collett, J. A., Yeo, K. H. J., Wilkinson, I. D., … Barclay, M. L., … George, P. M. (2000). The prevalence of viral hepatitis (HAV, HBV and HCV) in the Christchurch community. New Zealand Medical Journal, 113, 394-396.

Cook, H. B., Burt, M. J., Collett, J. A., Whitehead, M. R., Frampton, C. M., & Chapman, B. A. (2000). Adult coeliac disease: Prevalence and significance. Journal of Gastroenterology & Hepatology, 15, 1032-1036.

Thomas, P. D., Turner, J. G., Dobbs, B. R., Burt, M. J., & Chapman, B. A. (2000). Use of 99mTc-DISIDA diliary scanning with morphine provocation for the detection of elevated shincter of Oddi basal pressure. Gut, 46, 838-841.

Stott, M. K., Fellowes, A. P., Upton, J. D., Burt, M. J., & George, P. M. (2000). Correction for Stoff et al: Simple multiplex PCR for the simultaneous detection of the C282Y and H63D hemochromatosis (HFE) gene mutations. Clinical Chemistry, 46, 308-309.

Chapman, B. A., Frampton, C. M., Wilson, I. R., Chisholm, R. J., Allan, R. B., & Burt, M. J. (2000). Gallstone prevalence in Christchurch: Risk factors and clinical significance. New Zealand Medical Journal, 113, 46-48.

1999

Journal - Research Article

Collett, J. A., Burt, M. J., Frampton, C. M. A., Yeo, K. H. J., Chapman, T. M., Buttimore, R. C., … Chapman, B. A. (1999). Seroprevalence of helicobacter pylori in an adult population in Christchurch: Risk factors and relationship to dyspeptic symptoms. New Zealand Medical Journal, 112(1093), 292-295.

Florkowski, C. M., George, P. M., Willis, J., Stott, M. K., Burt, M. J., Upton, J. D., … Scott, R. S. (1999). Haemochromatosis gene mutations Cys282Tyr and His63Asp are not increased in type 2 diabetic patients compared with the Canterbury (New Zealand) general population. Diabetes Research & Clinical Practice, 43, 199-203.

Collett, J. A., Burt, M. J., Frampton, C. M., Yeo, K. H. J., Chapman, T. M., Buttimore, R. C., … Chapman, B. A. (1999). Seroprevalence of Helicobacter pylori in the adult population of Christchurch: risk factors and relationship to dyspeptic symptoms and iron studies. New Zealand Medical Journal, 112, 292-295.

Stott, M. K., Fellowes, A. P., Upton, J. D., Burt, M. J., & George, P. M. (1999). Simple multiplex PCR for the simultaneous detection of the C282Y and H63D hemochromatosis (HFE) gene mutations. Clinical Chemistry, 45(3), 426-428.

1998

Journal - Research Article

Burt, M. J., George, P. M., Upton, J. D., Collett, J. A., Chapman, P. T., Walmsley, T. A., Chapman, B. A., & Frampton, C. M. (1998). The frequency and effect on iron indices of haemochromatosis (HFE) gene mutations. Gut, 43, 830-836.

Collett, J. A., Allan, R., Chisholm, R. J., Wilson, I. R., Burt, M. J., & Chapman, B. A. (1998). Gallbladder polyps: A prospective study. Journal of Ultrasound in Medicine, 17(4), 207-211.

Burt, M. J., George, P. M., Upton, J. D., Collett, J. A., Frampton, C. M., Chapman, B. A., … Walmsley, T. A. (1998). The frequency and significance of hemochromatosis (HFE) mutations in the general population. Gut, 43(6), 830-836.

Collett, J. A., Allan, R. B., Chisholm, R. J., Wilson, I. R., Burt, M. J., & Chapman, B. A. (1998). Gallbladder polyps: prospective study. Journal of Ultrasound in Medicine, 17(4), 207-211.

Chapman, B. A., Burt, M. J., Chisholm, R. J., Allan, R. B., Yeo, K. H. J., & Ross, A. G. (1998). Dissolution of gallstones with simvastatin, an HMG CoA reductase inhibitor. Digestive Diseases & Sciences, 43(2), 349-353.

Chapman, B. A., Chapman, T. M., Frampton, C. M., Chisholm, R. J., Allan, R. B., Wilson, I. R., & Burt, M. J. (1998). Gallbladder volume: comparison of diabetic and controls. Digestive Diseases & Sciences, 43(2), 344-348.

Burt, M. J., & Cooksley, W. G. (1998). The influence of iron on chronic Hepatitis C. Journal of Gastroenterology & Hepatology, 13(3), 330-333.

1997

Journal - Research Article

Burt, M. J., Upton, J. D., Morison, I. M., Chapman, B. A., Faed, J. M., & George, P. M. (1997). Molecular analysis of HLA-H gene mutations in New Zealand patients with haemochromatosis. New Zealand Medical Journal, 110(1056), 429-432.

Frizelle, F. A., & Burt, M. J. (1997). Review: the surgical management of ulcerative colitis. Journal of Gastroenterology & Hepatology, 12(9/10), 670-677.

Allardyce, R. A., Chapman, B. A., Tie, A. B., Burt, M. J., Yeo, K. J., Keenan, J. I., & Bagshaw, P. F. (1997). 37 kBq ¹⁴C-urea breath test and gastric biopsy analysis of H. pylori infection. Australian & New Zealand Journal of Surgery, 67(1), 31-34. doi: 10.1111/j.1445-2197.1997.tb01890.x

Journal - Professional & Other Non-Research Articles

Jazwinska, E. C., Cullen, L., Zournazi, A., Burt, M. J., van der Griend, B., Goldwurm, S., & Little, P. F. (1997). Isolation and characterisation of cosmids to intervals within a 4.5Mb region at 6p21.3. DNA Sequence, 8(3), 147-150.

1996

Journal - Research Article

Burt, M. J., George, D. K., & Powell, L. W. (1996). Haemochromatosis a clinical update. Medical Journal of Australia, 164, 348-351.

Powell, L. W., Burt, M. J., Halliday, J. W., & Jazwinska, E. C. (1996). Hemochromatosis: genetics and pathogenesis. Seminars in Liver Disease, 16, 55-63.

Burt, M. J., Smit, D. J., Pyper, W. R., Powell, L. W., & Jazwinska, E. C. (1996). A 4.5-megabase YAC contig and physical map over the hemochromatosis gene region. Genomics, 33, 153-158.

Burt, M. J., Ross, A. G., Schroeder, B. A., Chambers, S., & Chapman, B. A. (1996). Evaluation of alpha inferferon for the treatment of chronic hepatitis B infection in Christchurch. New Zealand Medical Journal, 109, 162-164.

Burt, M. J., Jazwinska, E. C., Gill, D., Lynch, S. V., Kerlin, P., Steadman, C. J., … Powell, E. E. (1996). Detection of circulating donor DNA by microsatellite analysis in a liver transplant recipient. Liver Transplantation & Surgery, 2, 1-5.

1995

Journal - Research Article

Pyper, W. R., Burt, M. J., Powell, L. W., Webb, S., Ades, L., Halliday, J. W., & Jazwinska, E. A. (1995). A region of primer binding variation at the D6S265 locus associated with HLA-A25 and HLA-A26 antigens. Human Genetics, 96, 490-492.